ProShare Advisors LLC - DAY ONE BIOPHARMACEUTICALS I ownership

DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 137 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of DAY ONE BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$169,620
+27.2%
13,824
+23.8%
0.00%
Q2 2023$133,298
-35.8%
11,164
+15.7%
0.00%
-100.0%
Q4 2022$207,560
+95.8%
9,645
-9.6%
0.00%
Q1 2022$106,000
-43.6%
10,675
-4.1%
0.00%
Q4 2021$188,00011,1270.00%
Other shareholders
DAY ONE BIOPHARMACEUTICALS I shareholders Q2 2023
NameSharesValueWeighting ↓
Canaan Partners XI LLC 2,548,403$30,427,93221.55%
Atlas Venture Life Science Advisors, LLC 7,608,394$90,844,22411.30%
Nicholas Investment Partners, LP 2,237,111$26,711,1051.83%
RA Capital Management 7,809,852$93,249,6331.76%
DAFNA Capital Management LLC 507,100$6,054,7741.66%
BRAIDWELL LP 3,361,813$40,140,0471.31%
APIS CAPITAL ADVISORS, LLC 90,000$1,074,6001.08%
Logos Global Management LP 650,000$7,761,0001.06%
CVI Holdings, LLC 80,000$955,2001.00%
COMMODORE CAPITAL LP 739,661$8,831,5520.99%
View complete list of DAY ONE BIOPHARMACEUTICALS I shareholders